Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A multicentre randomised study on percutaneous stellate ganglion block as first-line treatment in patients with electrical storm: the STAR 2… Not authorised

2024-520387-34-00 electrical storm 6
MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction Not authorised

2023-507296-21-00 Acute Myocardial Infarction 5
SAFEST Not authorised

2022-502059-79-00 Ischemic stroke or transient ischemic attack 6
Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised

2024-516074-29-00 Cardiac arrest 5
A Masked, Multicentre, Placebo-controlled, Randomized Phase IIa Clinical Trial to investigate the safety and efficacy of ApTOLL in a populat… Not authorised

2023-503751-97-00 STEMI (ST Elevation Myocardial Infarct) 4
MK-0616-013 Not authorised

2022-502777-42-00 Hypercholesterolemia 5
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Not authorised

2022-502781-24-00 ASCVD - Atherosclerotic Cardiovascular Disease 11
AP01 Heart Failure (AHF) Study Not authorised

2023-507573-17-01 Acute Heart Failure 4
A Phase I-IIa Trial on the Safety and Preliminary Effectiveness of Intramyocardial Injection of Allogeneic Cardiac Atrial Stem Cells for the… Not authorised

2024-517031-51-00 Heart Failure 7
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the t… Not authorised

2025-523374-17-01 Type 2 diabetes 6
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
SGLT2 lnhibition in Hemodialysis (DAPA-HD) Pending

2024-518591-31-00 Chronic Kidney Disease 4
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension 10
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY) Pending

2024-519107-10-00 transthyretin cardiac amyloidosis 6
Colchicine to inhibit atherosclerosis in patients with cancer receiving immune therapy Pending

2024-518100-45-00 Atherosclerosis 5
ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending

2025-521478-32-00 PEDIATRIC ACUTE MYOCARDITIS 5
Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin… Pending

2025-521481-10-00 Acute Myocardial Infarction 6
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending

2024-516279-34-00 Pulmonary Hypertension 6
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia after Distal Revascularization: a randomized, double-blind trial Pending

2025-524297-42-00 CLTI defined as Rutherford category 4 or 5 5
REVITALISE Study Pending

2025-522060-32-00 STEMI (ST elevated Myocardial Infarction) 4
Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease Pending

2024-518640-20-00 Chronic ischemic heart disease 4
Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY) Pending

2024-519737-30-00 Roux-en-Y gastric bypass 6
SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection… Pending

2024-518146-25-00 patients with atrial fibrillation and preserved left ve 5
RANDOMIZED, CONTROLLED, OPEN TRIAL OF TWO STANDARDIZED DECLINE SCHEMES, FAST (NORTH AMERICAN) AND SLOW (EUROPEAN) RESPECTIVELY, OF CORTISONE… Pending

2024-518653-41-00 Patients with giant cell arteritis (= Horton’s disease) 5